BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
Clinical trial NCT03737344 · COMPLETED
Trial details
- NCT number
- NCT03737344
- Sponsor
- Adrian Parry-Jones
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-17
- Primary completion
- 2021-02-19
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.